Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02273752
Title Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

Her2-receptor negative breast cancer

renal cell carcinoma

pancreatic endocrine carcinoma

Therapies

Everolimus

Age Groups: adult
Covered Countries USA


No variant requirements are available.